These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 4297018

  • 1. Effects of the potent nephrotogenic aminonucleoside of puromycin on phospholipid metabolism in rat kidney cortex subcellular fractions.
    Bartlett P, Bossart JF.
    Henry Ford Hosp Med J; 1968; 16(2):137-46. PubMed ID: 4297018
    [No Abstract] [Full Text] [Related]

  • 2. Metabolism of puromycin aminonucleoside in the normal, "pre-nephrotic," and nephrotic rat.
    Derr RF, Alexander CS, Nagasawa HT.
    Proc Soc Exp Biol Med; 1967 May; 125(1):248-52. PubMed ID: 6027536
    [No Abstract] [Full Text] [Related]

  • 3. Metabolic basis of aminonucleoside nephrosis in rats. I. Inhibition of alpha-oxoglutarate oxidation by aminonucleoside.
    Yoshida T, Yamashita F, Metcoff J.
    J Lab Clin Med; 1968 Oct; 72(4):565-75. PubMed ID: 4300304
    [No Abstract] [Full Text] [Related]

  • 4. Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside.
    Gherardi E, Calandra S.
    Biochim Biophys Acta; 1982 Feb 15; 710(2):188-96. PubMed ID: 7066357
    [Abstract] [Full Text] [Related]

  • 5. The fibrinolytic enzyme system of the rat: the effect of aminonucleoside-induced nephrotic syndrome.
    Marsh NA.
    Br J Exp Pathol; 1969 Feb 15; 50(1):1-12. PubMed ID: 5773142
    [Abstract] [Full Text] [Related]

  • 6. Experimental nephrotic syndrome induced in the rat by puromycin aminonucleoside: hepatic synthesis of neutral lipids and phospholipids from 3H-water and 3H-palmitate.
    Gherardi E, Calandra S.
    Lipids; 1980 Feb 15; 15(2):108-12. PubMed ID: 7374358
    [No Abstract] [Full Text] [Related]

  • 7. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
    Klein DJ, Dehnel PJ, Oegema TR, Brown DM.
    Lab Invest; 1984 May 15; 50(5):543-51. PubMed ID: 6232422
    [Abstract] [Full Text] [Related]

  • 8. Morphometry of the glomeruli in puromycin aminonucleoside nephrotic syndrome.
    Pinto JA, Brewer DB.
    J Pathol; 1973 Jan 15; 109(1):Pxi. PubMed ID: 4719760
    [No Abstract] [Full Text] [Related]

  • 9. Interaction of aminonucleoside-8-14C with subcellular fractions of rat kidney cortex.
    Bartlett P, Bossart JF, Podsiadly CJ.
    Life Sci; 1969 Dec 15; 8(24):1299-307. PubMed ID: 5363363
    [No Abstract] [Full Text] [Related]

  • 10. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J, Nakajima K, Ohno Y, Kaneshiro Y, Matsuo T, Tanaka H, Kaneko K.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):239-44. PubMed ID: 18541230
    [Abstract] [Full Text] [Related]

  • 11. Effects of buffer systems on the interaction of the potent nephrotogenic aminonucleoside of puromycin with rat kidney cortex microsomes.
    Podsiadly C, Bartlett P.
    Biochem Biophys Res Commun; 1969 Oct 22; 37(3):464-9. PubMed ID: 5349283
    [No Abstract] [Full Text] [Related]

  • 12. [Influence of corticosteroid on phosphatidylinositol turnover in aminonucleoside-induced nephrotic rat kidney].
    Watanabe K, Suzuki J, Suzuki H.
    Nihon Jinzo Gakkai Shi; 1996 Sep 22; 38(9):393-8. PubMed ID: 8913091
    [Abstract] [Full Text] [Related]

  • 13. Metabolic basis of aminonucleoside nephrosis in rats. II. Inhibition of renal gluconeogenesis by aminonucleoside.
    Yoshida T, Metcoff J.
    J Lab Clin Med; 1968 Oct 22; 72(4):576-81. PubMed ID: 5677305
    [No Abstract] [Full Text] [Related]

  • 14. TISSUE GLYCOGEN LEVELS IN ANIMALS TREATED WITH THE AMINONUCLEOSIDE OF PUROMYCIN.
    KMETEC E, HEYMANN W.
    Am J Physiol; 1964 Dec 22; 207():1295-9. PubMed ID: 14251934
    [No Abstract] [Full Text] [Related]

  • 15. Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins.
    Gherardi E, Vecchia L, Calandra S.
    Exp Mol Pathol; 1980 Apr 22; 32(2):128-42. PubMed ID: 7364013
    [No Abstract] [Full Text] [Related]

  • 16. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C, Edwards KD, Paoletti R.
    Life Sci II; 1970 May 08; 9(9):523-34. PubMed ID: 5452796
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of aminonucleoside nephrosis in rats. IV. Prevention by N6-methyladenosine.
    Derr RF, Loechler DK, Alexander CS, Nagasawa HT.
    J Lab Clin Med; 1968 Sep 08; 72(3):363-9. PubMed ID: 5674067
    [No Abstract] [Full Text] [Related]

  • 18. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
    Sampaio-Maia B, Moreira-Rodrigues M, Serrão P, Pestana M.
    Nephrol Dial Transplant; 2006 Feb 08; 21(2):314-23. PubMed ID: 16204272
    [Abstract] [Full Text] [Related]

  • 19. Aminonucleoside nephropathy. An experimental study.
    Mathur KS, Wahal PK, Singh KK.
    J Assoc Physicians India; 1968 Jan 08; 16(1):1-8. PubMed ID: 5655058
    [No Abstract] [Full Text] [Related]

  • 20. Effects of the potent nephrotogenic aminonucleoside of puromycin on mitochondrial mechanochemistry.
    Maeda J, Bartlett P.
    Biochem Pharmacol; 1967 May 08; 16(5):761-8. PubMed ID: 6036727
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.